Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation

被引:22
作者
Kim, M. [1 ]
Yahng, S-A [2 ]
Kwon, A. [1 ]
Park, J. [1 ]
Jeon, Y-W [2 ]
Yoon, J-H [2 ]
Shin, S-H [2 ]
Lee, S-E [2 ]
Cho, B-S [2 ]
Eom, K-S [2 ]
Lee, S. [2 ]
Min, C-K [2 ]
Kim, H-J [2 ]
Cho, S-G [2 ]
Kim, D-W [2 ]
Lee, J-W [2 ]
Min, W-S [2 ]
Lee, S-H [3 ]
Kim, Y-J [2 ]
机构
[1] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Lab Med, Seoul, South Korea
[2] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Catholic Blood & Marrow Transplantat Ctr, Seoul, South Korea
[3] Catholic Univ Korea, Coll Med, Dept Pathol, Seoul, South Korea
关键词
SF3B1; MACHINERY; AGENTS; SRSF2; U2AF1;
D O I
10.1038/bmt.2015.110
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:1132 / 1134
页数:3
相关论文
共 15 条
[1]   TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients [J].
Bejar, Rafael ;
Lord, Allegra ;
Stevenson, Kristen ;
Bar-Natan, Michal ;
Perez-Ladaga, Albert ;
Zaneveld, Jacques ;
Wang, Hui ;
Caughey, Bennett ;
Stojanov, Petar ;
Getz, Gad ;
Garcia-Manero, Guillermo ;
Kantarjian, Hagop ;
Chen, Rui ;
Stone, Richard M. ;
Neuberg, Donna ;
Steensma, David P. ;
Ebert, Benjamin L. .
BLOOD, 2014, 124 (17) :2705-2712
[2]   Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation [J].
Bejar, Rafael ;
Stevenson, Kristen E. ;
Caughey, Bennett ;
Lindsley, R. Coleman ;
Mar, Brenton G. ;
Stojanov, Petar ;
Getz, Gad ;
Steensma, David P. ;
Ritz, Jerome ;
Soiffer, Robert ;
Antin, Joseph H. ;
Alyea, Edwin ;
Armand, Philippe ;
Ho, Vincent ;
Koreth, John ;
Neuberg, Donna ;
Cutler, Corey S. ;
Ebert, Benjamin L. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) :2691-+
[3]   Clinical Effect of Point Mutations in Myelodysplastic Syndromes [J].
Bejar, Rafael ;
Stevenson, Kristen ;
Abdel-Wahab, Omar ;
Galili, Naomi ;
Nilsson, Bjoern ;
Garcia-Manero, Guillermo ;
Kantarjian, Hagop ;
Raza, Azra ;
Levine, Ross L. ;
Neuberg, Donna ;
Ebert, Benjamin L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (26) :2496-2506
[4]   Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia [J].
Cheson, Bruce D. ;
Greenberg, Peter L. ;
Bennett, John M. ;
Lowenberg, Bob ;
Wijermans, Pierre W. ;
Nimer, Stephen D. ;
Pinto, Antonio ;
Beran, Miloslav ;
de Witte, Theo M. ;
Stone, Richard M. ;
Mittelman, Moshe ;
Sanz, Guillermo F. ;
Gore, Steven D. ;
Schiffer, Charles A. ;
Kantarjian, Hagop .
BLOOD, 2006, 108 (02) :419-425
[5]   Landscape of genetic lesions in 944 patients with myelodysplastic syndromes [J].
Haferlach, T. ;
Nagata, Y. ;
Grossmann, V. ;
Okuno, Y. ;
Bacher, U. ;
Nagae, G. ;
Schnittger, S. ;
Sanada, M. ;
Kon, A. ;
Alpermann, T. ;
Yoshida, K. ;
Roller, A. ;
Nadarajah, N. ;
Shiraishi, Y. ;
Shiozawa, Y. ;
Chiba, K. ;
Tanaka, H. ;
Koeffler, H. P. ;
Klein, H-U ;
Dugas, M. ;
Aburatani, H. ;
Kohlmann, A. ;
Miyano, S. ;
Haferlach, C. ;
Kern, W. ;
Ogawa, S. .
LEUKEMIA, 2014, 28 (02) :241-247
[6]   Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors [J].
Je, Eun Mi ;
Yoo, Nam Jin ;
Kim, Yoo Jin ;
Kim, Myung Shin ;
Lee, Sug Hyung .
INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (01) :260-265
[7]   International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome [J].
Kita-Sasai, Y ;
Horiike, S ;
Misawa, S ;
Kaneko, H ;
Kobayashi, M ;
Nakao, M ;
Nakagawa, H ;
Fujii, H ;
Taniwaki, M .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (02) :309-312
[8]   Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis [J].
Makishima, Hideki ;
Visconte, Valeria ;
Sakaguchi, Hirotoshi ;
Jankowska, Anna M. ;
Abu Kar, Sarah ;
Jerez, Andres ;
Przychodzen, Bartlomiej ;
Bupathi, Manoj ;
Guinta, Kathryn ;
Afable, Manuel G. ;
Sekeres, Mikkael A. ;
Padgett, Richard A. ;
Tiu, Ramon V. ;
Maciejewski, Jaroslaw P. .
BLOOD, 2012, 119 (14) :3203-3210
[9]   Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms [J].
Malcovati, Luca ;
Papaemmanuil, Elli ;
Bowen, David T. ;
Boultwood, Jacqueline ;
Della Porta, Matteo G. ;
Pascutto, Cristiana ;
Travaglino, Erica ;
Groves, Michael J. ;
Godfrey, Anna L. ;
Ambaglio, Ilaria ;
Galli, Anna ;
Da Via, Matteo C. ;
Conte, Simona ;
Tauro, Sudhir ;
Keenan, Norene ;
Hyslop, Ann ;
Hinton, Jonathan ;
Mudie, Laura J. ;
Wainscoat, James S. ;
Futreal, P. Andrew ;
Stratton, Michael R. ;
Campbell, Peter J. ;
Hellstrom-Lindberg, Eva ;
Cazzola, Mario .
BLOOD, 2011, 118 (24) :6239-6246
[10]   Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts [J].
Papaemmanuil, E. ;
Cazzola, M. ;
Boultwood, J. ;
Malcovati, L. ;
Vyas, P. ;
Bowen, D. ;
Pellagatti, A. ;
Wainscoat, J. S. ;
Hellstrom-Lindberg, E. ;
Gambacorti-Passerini, C. ;
Godfrey, A. L. ;
Rapado, I. ;
Cvejic, A. ;
Rance, R. ;
McGee, C. ;
Ellis, P. ;
Mudie, L. J. ;
Stephens, P. J. ;
McLaren, S. ;
Massie, C. E. ;
Tarpey, P. S. ;
Varela, I. ;
Nik-Zainal, S. ;
Davies, H. R. ;
Shlien, A. ;
Jones, D. ;
Raine, K. ;
Hinton, J. ;
Butler, A. P. ;
Teague, J. W. ;
Baxter, E. J. ;
Score, J. ;
Galli, A. ;
Della Porta, M. G. ;
Travaglino, E. ;
Groves, M. ;
Tauro, S. ;
Munshi, N. C. ;
Anderson, K. C. ;
El-Naggar, A. ;
Fischer, A. ;
Mustonen, V. ;
Warren, A. J. ;
Cross, N. C. P. ;
Green, A. R. ;
Futreal, P. A. ;
Stratton, M. R. ;
Campbell, P. J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15) :1384-1395